GRAL GRAIL, Inc.
Healthcare$67.19-0.99%ClosedMarket Cap: $2.88B
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$75.67
Target (Median)
$65.00
Target Range
$56.00 - $130.00
Upside from current price: 12.6%
Rating Distribution
0 Strong Buy4 Buy4 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-06 | Piper Sandler | maintain | Neutral | Neutral |
| 2026-05-06 | TD Cowen | maintain | Buy | Buy |
| 2026-03-30 | Guggenheim | maintain | Buy | Buy |
| 2026-02-24 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| 2026-02-20 | Baird | maintain | Outperform | Outperform |
| 2026-02-20 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-01-26 | Guggenheim | maintain | Buy | Buy |
| 2025-12-02 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| 2025-11-17 | Canaccord Genuity | maintain | Buy | Buy |
| 2025-11-12 | Guggenheim | upgrade | Buy | Neutral |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-10.89 | $224.3M | 4 |
| Sun Dec 31 | $-10.32 | $284.5M | 7 |
| Mon Dec 31 | $-10.42 | $377.6M | 2 |
| Tue Dec 31 | $-9.56 | $492.5M | 5 |